DNA Synthesis Market Analysis

DNA Synthesis Market Analysis

To get key market trends

  Download Free Sample

Based on service, the market is segmented into oligonucleotide synthesis and gene synthesis. The oligonucleotide synthesis segment is further divided into standard oligonucleotide synthesis and custom oligonucleotide synthesis. Oligonucleotide synthesis segment dominated the market in 2023 with a market share of 58%.
 

• The oligonucleotide synthesis segment holds a significant market share in the market due to its crucial role in various applications, including genetic testing, molecular diagnostics, synthetic biology, and gene editing.
   
• Oligonucleotides are synthesized with specific base pairs using nucleotide strands, serve primarily as primers and probes in biological processes. The synthesis technique offers a swift and cost-effective means to produce desired sequences witnessing its higher demand.
   
• Moreover, advancements in technology, such as automated synthesizers and high-throughput platforms, are further fueling the market's expansion by enhancing the efficiency and scalability of oligonucleotide synthesis
   

Based on method, the DNA synthesis market is segmented into solid-phase synthesis, PCR-based enzyme synthesis, and chip-based synthesis. The solid-phase synthesis segment accounted for significant market share in 2023 and is poised to capture the market size of USD 9 billion by 2032.
 

• The dominance of solid-phase synthesis arises from its efficiency and versatility in constructing DNA sequences on solid supports, facilitating step-by-step nucleotide addition. Also, its controlled, automated nature ensures precise oligonucleotide synthesis, minimizing errors and maximizing yield, appealing to the market.
   
• Furthermore, high scalability and cost-effectiveness of solid-phase synthesis method makes it favourable for both research and industrial applications, establishing it as the preferred method for custom DNA production across diverse sectors, solidifying its dominance in the market.
   

Based on application, the DNA synthesis market is segmented into research and development, diagnostics, and therapeutics. The research and development segment dominated the market in 2023 and is anticipated to grow at a CAGR of 19.3% over the analysis period.
 

• Research and development hold a significant market share in the market due to its crucial role in advancing biotechnology and pharmaceutical research. This segment encompasses activities aimed at developing new DNA synthesis techniques, enhancing existing methodologies, and exploring novel applications of synthetic DNA.
   
• Further, the growing demand for custom DNA sequences for experimental studies, drug discovery, and genetic engineering purposes fuels the growth of DNA synthesis. For instance, according to SynBioBeta, the global bio-engineering sector utilizes over 3 kg of nucleotide bases annually for diverse research purposes. Therefore, the increasing adoption of nucleotides reflected a rising emphasis on DNA research.
   
• Thus, as the demand for customized DNA sequences for various research purposes grows, the research and development segment is poised to maintain its high market share by continually pushing the boundaries of what is possible in synthetic biology.
   

Based on end use, the DNA synthesis market is segmented into biopharmaceutical companies, academic & research institutes, and contract research organizations. Biopharmaceutical companies’ segment is anticipated to growth at a CAGR of 18.4% between 2024 – 2032.
 

• This growth is driven by the increasing demand for personalized medicine, where DNA synthesis plays a critical role in creating customized treatments tailored to individual patients' genetic makeup.
   
• Biopharmaceutical companies are increasingly investing in DNA synthesis technologies to accelerate drug discovery and development processes, leading to the creation of novel therapies for various diseases.  Therefore, as these companies continue to innovate and collaborate with research institutions, the biopharmaceutical companies’ segment is expected to experience significant growth in the coming years.
   
• Additionally, the rising prevalence of genetic disorders and the expanding applications of DNA synthesis in gene editing and gene therapy further contribute to the segment's growth potential.
   

North America dominated the global DNA synthesis market in 2023 with a market share of 36.5% and is anticipated to grow at a CAGR of 18.4% over the analysis period.
 

• The region’s robust R&D infrastructure, coupled with concentration of key players and leading research institutions specializing in synthetic biology and gene editing technologies contribute to the region’s dominance in the genome field.
   
• For instance, increasing research funding and strategic initiatives by key players has stimulated studies aimed at addressing the demand for effective treatments for chronic diseases. In April 2021, DNAScript partnered with Moderna, along with USD 5 million grant from the U.S. Defense Advanced Research Projects Agency (DARPA). This collaboration aimed in creating a prototype for the efficient manufacturing of therapeutics and vaccines, as part of the global nucleic acids on-demand program.
   
• Such initiatives highlight the region's leadership in fostering partnerships between innovative companies and government agencies, aimed in advancing DNA synthesis technologies for critical healthcare solutions.
   

The U.S. DNA synthesis market is anticipated to grow at a CAGR of 18.3% between 2024 – 2032.
 

• The country's well-established regulatory framework and supportive government policies further contribute to market growth, facilitating innovation and commercialization of DNA synthesis technologies.
   
• Additionally, the high demand for synthetic DNA in various applications such as genetic engineering, drug development, and personalized medicine drives the market.
   
• The extensive adoption of DNA synthesis in academic and industrial research, coupled with a robust supply chain and distribution network, solidifies the U.S. as a key player in the market.

Europe DNA synthesis market was valued at USD 1.1 billion in 2023 and is projected to reach USD 5.3 billion by 2032.
 

• Europe is home to many pharmaceutical and biotechnology companies, which are major consumers of synthetic DNA for drug discovery, development, and manufacturing purposes. These companies often require custom-designed DNA sequences for various applications, including protein expression, gene editing, and molecular diagnostics, driving the demand for DNA synthesis services.
   
• Secondly, Europe has a strong academic and research infrastructure, with renowned universities and research institutes conducting cutting-edge research in genomics, synthetic biology, and related fields. This research generates a constant demand for synthetic DNA for experimental purposes, further boosting the market.
   

Asia Pacific region is anticipated to witness high growth in DNA synthesis market, growing at a CAGR of 19.6% over the analysis years.
 

• The region is witnessing a significant increase in research and development activities, particularly in the fields of biotechnology, pharmaceuticals, and genetic engineering. This surge is fuelled by a growing emphasis on precision medicine, personalized healthcare, and advancements in synthetic biology.
   
• Additionally, a rising prevalence of diseases in the region is driving the need for genetic testing and personalized medicine. This trend is leading to increased demand for custom DNA synthesis services, further fuelling market growth.